Literature DB >> 4397737

Cellular and humoral response to transplantation antigens. I. Development of alloantibody-forming cells and cytotoxic lymphocytes in the graft-versus-host reaction.

J C Cerottini, A A Nordin, K T Brunner.   

Abstract

After transfer into heavily-irradiated allogeneic mice, spleen cells were found to produce two types of effector cells directed against the recipient alloantigens, namely alloantibody plaque-forming cells (PFC) and cytotoxic lymphocytes (CL). Both types of effector cells were detectable in vitro by virtue of their lytic effect on target cells carrying the recipient alloantigens. Alloantibody PFC activity was dependent on the presence of an exogenous source of complement and could be inhibited by the addition of heterologous antisera to mouse micro-chain or Fab fragment in the assay system. CL activity was independent of added complement, was not affected by anti-immunoglobulin antisera, but was inhibited by the addition of antibody against target cell alloantigens. Treatment of the transferred spleen cells with anti-theta-serum and complement before in vitro assays for PFC and CL completely abolished the CL activity but had no effect on alloantibody-plaque formation. These results indicate that the two types of effector cells can be differentiated in vitro by virtue of their susceptibility to anti-theta-serum and the mechanisms by which they cause cell lysis.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4397737      PMCID: PMC2139051          DOI: 10.1084/jem.134.2.553

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  The antibody response of mice to allografts as determined by a plaque assay with allogeneic target cells.

Authors:  A A Nordin; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements.

Authors:  G Haughton; M P McGehee
Journal:  Immunology       Date:  1969-04       Impact factor: 7.397

3.  Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens.

Authors:  J C Cerottini; A A Nordin; K T Brunner
Journal:  Nature       Date:  1970-12-26       Impact factor: 49.962

4.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  An antigen-binding capacity test for human immunoglobulin G (IgG) fragments.

Authors:  J C Cerottini
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

6.  Cell mediated immune reactions "in vitro". Reactivity of lymphocytes from animals sensitized to chicken erythrocytes, tuberculin or transplantation antigens.

Authors:  B Chapuis; K T Brunner
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

7.  Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.

Authors:  J Mauel; H Rudolf; B Chapuis; K T Brunner
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

8.  Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells.

Authors:  A Cohen; M Schlesinger
Journal:  Transplantation       Date:  1970-07       Impact factor: 4.939

9.  Quantitative in vitro assay of cytotoxic cellular immunity.

Authors:  T G Canty; J R Wunderlich
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

10.  Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

Authors:  K T Brunner; J Mauel; H Rudolf; B Chapuis
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

View more
  24 in total

1.  Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.

Authors:  H Warnatz; F Scheiffarth; R Schmeissner
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.

Authors:  E S Newlands; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

3.  T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.

Authors:  T L Whiteside; D T Rowlands
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

4.  Lymphocyte activation. IV. The ultrastructural pattern of the response of mouse T and B cells to mitogenic stimulation in vitro.

Authors:  G Janossy; M Shohat; M F Greaves; R R Dourmashkin
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

5.  The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.

Authors:  M Zembala; W Ptak; M Hanczakowska
Journal:  Immunology       Date:  1973-10       Impact factor: 7.397

6.  Macrophage and lymphocyte co-operation in target cell destruction in vitro.

Authors:  M Zembala; W Ptak; M Hanczakowska
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

7.  Cytotoxic lymphocytes in Hashimoto thyroiditis. An in vitro assay system using 51 Cr-labelled chicken red blood cells coated with thyroglobulin.

Authors:  B A Calder; W J Penhale; E W Barnes; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-05       Impact factor: 4.330

8.  Reactivity of anti-human brain serum with human lymphocytes.

Authors:  T L Whiteside
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

9.  Effect of age on cell-mediated immunity in long-lived mice.

Authors:  S A Goodman; T Makinodan
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

10.  Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

Authors:  H Warnatz; W Rösch; W Gerlich; W Gutmann
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.